Pharmaceuticals Industry in India 2015-2020: Pharmaceuticals Industry in India is Expected to be Worth US$ 55.39 Billion

News provided by

Sep 07, 2015, 07:10 ET

DUBLIN, Sep. 07, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/rnwppv/pharmaceuticals) has announced the addition of the "Pharmaceuticals Industry in India 2015-2020" report to their offering.

Pharmaceuticals Industry in India is expected to be worth US$ 55.39 billion by 2020. Indian pharmaceuticals market is expected to grow at a CAGR of 18% by 2020 driven by the aging and growing population, rising income levels, emerging medical conditions and new diseases.

The Indian Pharmaceutical Industry is in middle of big changes and not only the Industry is expected to accommodate Demographic, Epidemiological, and economic shifts in the world, but also has to upgrade manufacturing practices and match rigid standards from time to time in order to produce world-class medicines. Also, the pharmaceutical manufacturers are expected to embrace newer methods and effective practices - right from the ways drugs are discovered, then on manufacturing and packaging fronts, and to the ways drugs are made available to consumers.

The generics portfolio dominates the Indian Pharma Industry which accounts for over 70% of the market. The Indian Pharma market is largely fragmented. With a string of Mergers and Acquisitions within the market in the last decade, consolidation of the overall market has been the key Industry feature.

India's Pharmaceutical sector accounts for nearly 1.4% of the global pharmaceutical industry in terms of value 10% in terms of volume.

Medical devices manufacturing industry in India is expected to grow at a CAGR of 15% till 2020. Indian Medical Devices and Equipment industry is an import-led market and about 70%-80% of finished goods and related components are sourced from foreign countries. This trend is expected to continue till 2020.

Indian medical transcription Industry is expected to grow at a CAGR of 4.16% till 2020 found this study. The Pharma service predominantly includes Medical Transcription, Telemedicine, Clinical Trials, Clinical Data Management and Teleradiology amongst the others.

Key Topics Covered:

1. Executive Summary

2. Introduction - Pharma Industry in India

3. Need for Pharmaceuticals Industry in India

4. Market Segments & Forecast for Pharmaceuticals Industry in India

5. EXIM Scenario in Indian Pharmaceuticals Market

6. Growth Drivers and Inhibitors for Pharmaceuticals Industry in India

7. Policies Related to Pharmaceuticals Industry in India

8. Risks Associated with Pharmaceutical Industry in India

9. Industry Associations Related to Indian Pharmaceuticals Industry

10. Government Bodies Related to Indian Pharmaceuticals Industry

11. Profile of Key Players in India Pharmaceuticals Industry

12. Competitive Landscape in Pharmaceuticals Industry in India

13. Analysis of Indian Pharmaceutical Industry

14 Current & Future Trends in Pharmaceuticals Industry in India

15 Strategic Recommendations

Companies Mentioned

- Abbott India
- Apollo Pharmacy
- Aurobindo Pharma Limited
- Beacton Dickinson & Company Limited
- Biocon Limited
- CIPLA Limited
- Divis Laboratories Limited
- Dr. Reddy's Laboratories
- IPCA Laboratories Limited
- Lupin Limited
- MedPlus Health Services Pvt. Ltd.
- National Institute of Pharmaceutical Education and Research (NIPER)
- Novartis India Limited
- Poly Medicure Limited
- Sun Pharmaceuticals Limited
- Torrent Pharmaceuticals Limited

For more information visit http://www.researchandmarkets.com/research/rnwppv/pharmaceuticals